1
|
Moreno-Gordaliza E, van der Lee SJ, Demirkan A, van Duijn CM, Kuiper J, Lindenburg PW, Hankemeier T. A novel method for serum lipoprotein profiling using high performance capillary isotachophoresis. Anal Chim Acta 2016; 944:57-69. [DOI: 10.1016/j.aca.2016.09.038] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2016] [Revised: 09/29/2016] [Accepted: 09/30/2016] [Indexed: 01/22/2023]
|
2
|
Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. Mediators Inflamm 2013; 2013:971579. [PMID: 23983406 PMCID: PMC3742028 DOI: 10.1155/2013/971579] [Citation(s) in RCA: 63] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2013] [Accepted: 06/26/2013] [Indexed: 02/07/2023] Open
Abstract
Oxidation of low-density lipoprotein (LDL) has a key role in atherogenesis. Among the different models of oxidation that have been studied, the one using myeloperoxidase (MPO) is thought to be more physiopathologically relevant. Apolipoprotein B-100 is the unique protein of LDL and is the major target of MPO. Furthermore, MPO rapidly adsorbs at the surface of LDL, promoting oxidation of amino acid residues and formation of oxidized lipoproteins that are commonly named Mox-LDL. The latter is not recognized by the LDL receptor and is accumulated by macrophages. In the context of atherogenesis, Mox-LDL accumulates in macrophages leading to foam cell formation. Furthermore, Mox-LDL seems to have specific effects and triggers inflammation. Indeed, those oxidized lipoproteins activate endothelial cells and monocytes/macrophages and induce proinflammatory molecules such as TNFα and IL-8. Mox-LDL may also inhibit fibrinolysis mediated via endothelial cells and consecutively increase the risk of thrombus formation. Finally, Mox-LDL has been involved in the physiopathology of several diseases linked to atherosclerosis such as kidney failure and consequent hemodialysis therapy, erectile dysfunction, and sleep restriction. All these issues show that the investigations of MPO-dependent LDL oxidation are of importance to better understand the inflammatory context of atherosclerosis.
Collapse
|
3
|
Vaisar T. Proteomics investigations of HDL: challenges and promise. Curr Vasc Pharmacol 2012; 10:410-21. [PMID: 22339300 DOI: 10.2174/157016112800812755] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2011] [Revised: 09/01/2011] [Accepted: 11/06/2011] [Indexed: 02/02/2023]
Abstract
High density lipoprotein (HDL) is recognized as the major negative risk factor of cardiovascular disease and number of anti-atherogenic functions has been ascribed to HDL. HDL is an assembly of a neutral lipid core and an outer shell consisting of polar lipids and proteins. It has been defined many different ways based on various distinct properties including density flotation, protein composition, molecular size, and electrophoretic migration. Overall the studies characterizing HDL clearly demonstrate that it is a complex heterogeneous mixture of particles. Furthermore several studies convincingly demonstrated that certain populations of HDL particles have a distinct functionality suggesting that HDL may serve as a platform for assembly of protein complexes with very specific biological functions. Indeed recent proteomics studies described over 100 proteins associated with HDL. Here we review approaches to isolation and proteomic analysis of HDL and discuss potential problems associated with isolation methods which may confound our understanding of the relation of the HDL composition and its biological function.
Collapse
Affiliation(s)
- Tomáš Vaisar
- Diabetes and Obesity Center of Excellence, Department of Medicine, University of Washington, 815 Mercer St, Seattle, WA 98109, USA.
| |
Collapse
|
4
|
Larner CD, Henriquez RR, Johnson JD, Macfarlane RD. Developing high performance lipoprotein density profiling for use in clinical studies relating to cardiovascular disease. Anal Chem 2011; 83:8524-30. [PMID: 21970640 PMCID: PMC3220625 DOI: 10.1021/ac2018124] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022]
Abstract
![]()
Early detection of the beginning stage of cardiovascular disease
(CVD) is an approach to prevention because the process is reversible
at this stage. Consequently, several methods for screening for CVD
have been introduced in recent years incorporating different analytical
methods for characterizing the population of blood-borne lipoprotein
subclasses. The gold standard method for lipoprotein subclassification
is based on lipoprotein density measured by sedimentation equilibrium
using the ultracentrifuge. However, this method has not been adopted
for clinical studies because of difficulties in achieving the precision
required for distinguishing individuals with and without CVD particularly
when statistical classification methods are used. The objective of
this study was to identify and improve the major factors that influence
the precision of measurement of lipoprotein density profile by sedimentation
equilibrium analysis and labeling with a fluorescent probe. The study
has two phases, each contributing to precision. The first phase focuses
on the ultracentrifugation-related variables, and the second phase
addresses those factors involved in converting the fluorescent lipoprotein
density profile to a digital format compatible with statistical analysis.
The overall improvement in precision was on the order of a factor
of 5, sufficient to be effectively applied to ongoing classification
studies relating to CVD risk assessment.
Collapse
Affiliation(s)
- Craig D Larner
- Department of Chemistry, Texas A&M University, 3255 TAMU, College Station, Texas 77843-3255, United States
| | | | | | | |
Collapse
|
5
|
Scherer M, Böttcher A, Liebisch G. Lipid profiling of lipoproteins by electrospray ionization tandem mass spectrometry. Biochim Biophys Acta Mol Cell Biol Lipids 2011; 1811:918-24. [PMID: 21745591 DOI: 10.1016/j.bbalip.2011.06.016] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2011] [Revised: 05/30/2011] [Accepted: 06/14/2011] [Indexed: 10/18/2022]
Abstract
Lipoproteins are of fundamental importance for the lipid transport and cardiovascular disease. The function and metabolism of lipoproteins is intimately linked to the biophysical properties of their surface lipids. Although a number of disease associations were found for lipid species in plasma, only a few studies reported lipid profiles of lipoproteins. Here, we provide an overview of techniques for lipoprotein separation, methods for lipid species analysis based on electrospray ionization tandem mass spectrometry (ESI-MS/MS) as well as data from recent lipidomic studies on lipoprotein fractions. We also discuss the different analytical strategies and how lipid profiling can expand our understanding of the biology and structures of lipoproteins.
Collapse
|
6
|
Tache A, Cotrone S, Litescu SC, Cioffi N, Torsi L, Sabbatini L, Radu GL. Spectrochemical Characterization of Thin Layers of Lipoprotein Self-Assembled Films on Solid Supports Under Oxidation Process. ANAL LETT 2011. [DOI: 10.1080/00032711003790098] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
7
|
Characterization of in vitro modified human high-density lipoprotein particles and phospholipids by capillary zone electrophoresis and LC ESI-MS. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877:3495-505. [DOI: 10.1016/j.jchromb.2009.08.022] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2009] [Revised: 08/07/2009] [Accepted: 08/12/2009] [Indexed: 11/22/2022]
|
8
|
Langlois MR, Blaton VH. Historical milestones in measurement of HDL-cholesterol: Impact on clinical and laboratory practice. Clin Chim Acta 2006; 369:168-78. [PMID: 16579980 DOI: 10.1016/j.cca.2006.01.031] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2005] [Accepted: 01/31/2006] [Indexed: 11/16/2022]
Abstract
High-density lipoprotein cholesterol (HDL-C) comprises a family of particles with differing physicochemical characteristics. Continuing progress in improving HDL-C analysis has originated from two separate fields-one clinical, reflecting increased attention to HDL-C in estimating risk for coronary heart disease (CHD), and the other analytical, reflecting increased emphasis on finding more reliable and cost-effective HDL-C assays. Epidemiologic and prospective studies established the inverse association of HDL-C with CHD risk, a relationship that is consistent with protective mechanisms demonstrated in basic research and animal studies. Atheroprotective and less atheroprotective HDL subpopulations have been described. Guidelines on primary and secondary CHD prevention, which increased the workload in clinical laboratories, have led to a revolution in HDL-C assay technology. Many analytical techniques including ultracentrifugation, electrophoresis, chromatography, and polyanion precipitation methods have been developed to separate and quantify HDL-C and HDL subclasses. More recently developed homogeneous assays enable direct measurement of HDL-C on an automated analyzer, without the need for manual pretreatment to separate non-HDL. Although homogeneous assays show improved accuracy and precision in normal serum, discrepant results exist in samples with atypical lipoprotein characteristics. Hypertriglyceridemia and monoclonal paraproteins are important interfering factors. A novel approach is nuclear magnetic resonance spectroscopy that allows rapid and reliable analysis of lipoprotein subclasses, which may improve the identification of individuals at increased CHD risk. Apolipoprotein A-I, the major protein of HDL, has been proposed as an alternative cardioprotective marker avoiding the analytical limitations of HDL-C.
Collapse
Affiliation(s)
- Michel R Langlois
- Department of Clinical Chemistry, AZ St. Jan Hospital, Ruddershove 10, B-8000 Brugge, Belgium.
| | | |
Collapse
|
9
|
Chang WWP, Hobson C, Bomberger DC, Schneider LV. Rapid separation of protein isoforms by capillary zone electrophoresis with new dynamic coatings. Electrophoresis 2005; 26:2179-86. [PMID: 15861468 DOI: 10.1002/elps.200410283] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Many cellular functions are regulated through protein isoforms. Changes in the expression level or regulatory dysfunctions of isoforms often lead to developmental or pathological disorders. Isoforms are traditionally analyzed using techniques such as gel- or capillary-based isoelectric focusing. However, with proper electro-osmotic flow (EOF) control, isoforms with small pI differences can also be analyzed using capillary zone electrophoresis (CZE). Here we demonstrate the ability to quickly resolve isoforms of three model proteins (bovine serum albumin, transferrin, alpha1-antitrypsin) in capillaries coated with novel dynamic coatings. The coatings allow reproducible EOF modulation in the cathodal direction to a level of 10(-9) m2V(-1)s(-1). They also appear to inhibit protein adsorption to the capillary wall, making the isoform separations highly reproducible both in peak areas and apparent mobility. Isoforms of transferrin and alpha1-antitrypsin have been implicated in several human diseases. By coupling the CZE isoform separation with standard affinity capture assays, it may be possible to develop a cost-effective analytical platform for clinical diagnostics.
Collapse
|
10
|
Owen RL, Strasters JK, Breyer ED. Lipid vesicles in capillary electrophoretic techniques: characterization of structural properties and associated membrane-molecule interactions. Electrophoresis 2005; 26:735-751. [PMID: 15714573 DOI: 10.1002/elps.200410288] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
This paper reviews the use of lipid vesicles as model membranes in capillary electrophoresis (CE). The history and utility of CE in the characterization of microparticles is summarized, focusing on the application of colloidal electromigration theories to lipid vesicles. For instance, CE experiments have been used to characterize the size, surface properties, enclosed volumes, and electrophoretic mobilities of lipid vesicles and of lipoprotein particles. Several techniques involving small molecules or macromolecules separated in the presence of lipid vesicles are discussed. Interactions between the analytes and the lipid vesicles - acting as a pseudostationary phase or coated stationary phase in electrokinetic chromatography (EKC) - can be used to obtain additional information on the characteristics of the vesicles and analytes, and to study the biophysical properties of membrane-molecule interactions in lipid vesicles and lipoproteins. Different methods of determining binding constants by EKC are reviewed, along with the relevant binding constant calculations and a discussion of the application and limitations of these techniques as they apply to lipid vesicle systems.
Collapse
Affiliation(s)
- Rebecca L Owen
- Georgia State University, Department of Chemistry, Atlanta, GA 30302-4098, USA
| | | | | |
Collapse
|
11
|
Dergunov AD, Hoy A, Smirnova EA, Visvikis S, Siest G. Charge-based heterogeneity of human plasma lipoproteins at hypertriglyceridemia: capillary isotachophoresis study. Int J Biochem Cell Biol 2003; 35:530-43. [PMID: 12565713 DOI: 10.1016/s1357-2725(02)00359-x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
To reveal the metabolic links between and within pools of pro-atherogenic triglyceride(TG)-rich lipoproteins and anti-atherogenic high density lipoproteins (HDL), the changes in lipoprotein profile at hypertriglyceridemia were analyzed by capillary isotachophoresis. Plasma samples from patients with apoE3/3 phenotype were stained with a fluorescent probe NBD-C6-ceramide and lipoproteins resolved into six H-, one (V+I) and four L-components which belong to HDL, very low and intermediate density (VLDL+IDL) and low density lipoproteins (LDL), respectively. The expected correlation between the relative size of the combined fractions and lipid and apolipoprotein values was obtained confirming the validity of the approach. The new findings were obtained as follows. (1) The fast L-component correlated inversely with HDL-cholesterol (Chol), while intermediate and slow H-components correlated inversely with plasma and LDL-Chol and apoB. (2) The content of intermediate and slow H-components increased within H-pool and decreased relative TG-rich lipoproteins as hypertriglyceridemia rose due to the impairment of triglyceride hydrolysis by lipoprotein lipase within TG-rich particles. (3) A predictive value of the ratios of fast to slow H-components as an indicator of lecithin:cholesterol acyltransferase activity was demonstrated which tended to decrease at hypertriglyceridemia. (4) The L1/L2 ratio may be considered as an indicator of the accumulation of small dense LDL, which is a feature of clinically manifested atherogenic B-pattern. The competition between H(DL) and L(DL) particles for hepatic lipase and significant contribution of apoE to functional deficiency of H(DL) particles at hypertriglyceridemia are suggested.
Collapse
Affiliation(s)
- Alexander D Dergunov
- National Research Centre for Preventive Medicine, 10, Petroverigsky street, 101953, Moscow, Russia.
| | | | | | | | | |
Collapse
|
12
|
Petersen JR, Okorodudu AO, Mohammad A, Payne DA. Capillary electrophoresis and its application in the clinical laboratory. Clin Chim Acta 2003; 330:1-30. [PMID: 12636924 DOI: 10.1016/s0009-8981(03)00006-8] [Citation(s) in RCA: 72] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Over the past 10 years, capillary electrophoresis (CE) is an analytical tool that has shown great promise in replacing many conventional clinical laboratory methods, especially electrophoresis and high performance liquid chromatography (HPLC). The main attraction of CE was that it was fast, used small amounts of sample and reagents, and was extremely versatile, being able to separate large and small analytes, both neutral and charged. Because of this versatility, numerous methods for clinically relevant analytes have been developed. However, with the exception of the molecular diagnostic and forensic laboratories CE has not had a major impact. A possible reason is that CE is still perceived as requiring above-average technical expertise, precluding its use in a laboratory workforce that is less technically adept. With the introduction of multicapillary instruments that are more automated, less technique-dependent, in addition to the availability of commercial and cost effective test kit methods, CE may yet be accepted as a instrument routinely used in the clinical laboratories. Thus, this review will focus on the areas where CE shows the most potential to have the greatest impact on the clinical laboratory. These include analysis of proteins found in serum, urine, CSF and body fluids, immunosubstraction electrophoresis, hemoglobin variants, lipoproteins, carbohydrate-deficient transferrin (CDT), forensic and therapeutic drug screening, and molecular diagnostics.
Collapse
Affiliation(s)
- John R Petersen
- Department of Pathology, University of Texas Medical Branch, Galveston, USA.
| | | | | | | |
Collapse
|
13
|
Thormann W, Lurie IS, McCord B, Marti U, Cenni B, Malik N. Advances ofcapillary electrophoresis in clinical and forensic analysis (1999-2000). Electrophoresis 2001; 22:4216-43. [PMID: 11824639 DOI: 10.1002/1522-2683(200111)22:19<4216::aid-elps4216>3.0.co;2-w] [Citation(s) in RCA: 72] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
In this paper, capillary electrophoresis in clinical and forensic analysis is reviewed on the basis of the literature of 1999, 2000 and the first papers in 2001. An overview of progress relevant examples for each major field of application, namely (i) analysis of drug seizures, explosives residues, gunshot residues and inks, (ii) monitoring of drugs, endogenous small molecules and ions in biofluids and tissues, (iii) general screening for serum proteins and analysis of specific proteins (carbohydrate deficient transferrin, alpha1-antitrypsin, lipoproteins and hemoglobins) in biological fluids, and (iv) analysis of nucleic acids and oligonucleotides in biological samples, including oligonucleotide therapeutics, are presented.
Collapse
Affiliation(s)
- W Thormann
- Department of Clinical Pharmacology, University of Bern, Switzerland.
| | | | | | | | | | | |
Collapse
|